Pipotiazine palmitate is a small molecule drug with a maximum clinical trial phase of IV and is indicated in psychosis. It is grouped under the following drug class(es): Phenothiazine derivatives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Piportil depot and Pipotiazine Palmitic Ester. Its PubChem CID is 37767.
Pipotiazine palmitate
| CAS No | 37517-26-3 |
|---|---|
| Molecular Formula | C40H63N3O4S2 |
| Molecular Weight | 714.1 g/mol |
| Synonyms | 2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pipotiazine palmitate is a small molecule drug with a maximum clinical trial phase of IV and is indicated in psychosis. It is grouped under the following drug class(es): Phenothiazine derivatives.
The listed CAS number is 37517-26-3.
The listed molecular formula is C40H63N3O4S2.
The listed molecular weight is 714.1 g/mol.
2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoate.
The source lists Piportil depot and Pipotiazine Palmitic Ester.